back-button

    Gefitinib

    Information about Gefitinib

    Gefitinib uses

    Gefitinib is used in the treatment of non-small cell lung cancer
    It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

    How gefitinib works

    Gefitinib is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

    Common side effects of gefitinib

    Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth)

    Available Medicine for Gefitinib

    • ₹1966 to ₹5900
      Natco Pharma Ltd
      2 variant(s)
    • ₹3871
      Dr Reddy's Laboratories Ltd
      1 variant(s)
    • ₹3002
      Zuventus Healthcare Ltd
      1 variant(s)
    • ₹3847
      Glenmark Pharmaceuticals Ltd
      1 variant(s)
    • ₹3285
      Biochem Pharmaceutical Industries
      1 variant(s)
    • ₹3179
      Panacea Biotec Ltd
      1 variant(s)
    • ₹1904
      Emcure Pharmaceuticals Ltd
      1 variant(s)
    • ₹2476
      Celon Laboratories Ltd
      1 variant(s)
    • ₹3400
      United Biotech Pvt Ltd
      1 variant(s)
    • ₹2940
      Sun Pharmaceutical Industries Ltd
      1 variant(s)

    Expert advice for Gefitinib

    • Do not take antacids (to reduce the acid level of your stomach) 2 hours before or 1 hour after taking gefitinib.
    • Take the tablet at about the same time each day.
    • Do not give gefitinib to children.
    • Do not take gefitinib, if you are allergic to gefitinib or similar medicines or to any of the other ingredients.
    • Avoid using gefitinib, if you are pregnant or are breast-feeding.
    • Avoid becoming pregnant during treatment with gefitinib because it could harm your baby.
    • If you are taking a medicine containing warfarin as an active substance, your doctor may need to do blood tests more often.
    • You may feel weak while taking this medicine, be careful while driving or using tools or machines.

    Frequently asked questions for Gefitinib

    Gefitinib

    Q. Is Gefitinib a monoclonal antibody?
    No. It is not a monoclonal antibody.It is a tyrosine kinase inhibitors.

    Content on this page was last updated on 14 September, 2017, by Dr. Varun Gupta (MD Pharmacology)